Effects of mobile mindfulness meditation for the mental health of nurses: a protocol for a systematic review and meta-analysis

This article was originally published here

BMJ open. 2022 Apr 22;12(4):e058686. doi: 10.1136/bmjopen-2021-058686.

ABSTRACT

INTRODUCTION: Existing studies have shown that mobile-based mindfulness meditation (MMM) may have some impact on nurses’ mental health issues, but its specific effect and effect on specific mental health issues such that stress, anxiety, depression, mindfulness, well-being and resilience are unclear.

METHODS AND ANALYSIS: This study protocol follows the guidelines on preferred reporting items for systematic review and meta-analysis protocols. Electronic search via PubMed, Web of Science, EBSCO, Cochrane Library, CINAHL, PsycINFO, ERIC, Embase and three Chinese databases, namely CNKI, Wan Fang and Chinese Biology Medicine disc. The inclusion criteria follow the PICO principle, which is defined to translate the question into a searchable and searchable question. P (patient/population): clinical characteristics of the patients; I (intervention or exposure): treatment measures or exposure factors of concern; C (comparison): control measurement; O (result): result indicator of concern. Registered nurses, pre-registered nurses, midwives and nursing students will all be included, with studies using MMM as an intervention to improve nurses’ mental health, compared to wait list controls or groups of traditional methods, assessment of stress, anxiety, depression, mindfulness, well-being and resilience outcomes will meet inclusion criteria. Studies designed for quasi-experimental randomized controlled trials (RCTs) and written in English or Chinese will be eligible. The search time spanned from the creation of each database to July 2022. Two reviewers independently select and appraise studies for inclusion and extract data; any dispute will be settled by discussion. If the discussion still fails, the third author will make a decision. For RCTs, risk of bias will be assessed using the Cochrane risk of bias tool for randomized trials (RoB 2), and for non-RCT studies, risk of bias in intervention studies non-randomized (ROBINS-I) will be performed. A meta-analysis will be performed using RevMan software if a sufficient number of comparable studies are retrieved.

ETHICS AND DISSEMINATION: This is a meta-analysis study protocol; no primary data will be collected and no ethics review is required. The results of the study will be presented in a peer-reviewed scientific publication.

PROSPERO REGISTRATION NUMBER: CRD42021277932.

PMID:35459675 | DO I:10.1136/bmjopen-2021-058686

Comments are closed.